Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen and antigen targets recognized by IgG Fab refer to the specific molecular structures, known as epitopes, that are bound by the Fragment antigen-binding (Fab) region of Immunoglobulin G (IgG) antibodies (Schroeder & Cavacini, 2010). The Fab region is composed of one constant and one variable domain from each of the heavy and light chains, with the variable domains containing complementarity-determining regions (CDRs) that dictate specificity (Janeway et al., 2001). These targets encompass a vast array of molecules, including viral surface proteins, bacterial toxins, and tumor-associated antigens. Upon binding, the IgG molecule can neutralize the target's biological activity or facilitate its clearance through effector functions like opsonization or antibody-dependent cellular cytotoxicity (ADCC) (Forthal, 2014). In a therapeutic context, this 'target' is not a single entity but a broad category representing the diverse antigens addressed by monoclonal antibody therapies and vaccines (Lu et al., 2020). The interaction is characterized by high affinity and specificity, which are essential for the immune system to distinguish between self and non-self or healthy and diseased cells. Consequently, the term describes a functional class of interactions rather than a specific, individual therapeutic target.
The Fab region of IgG binds to specific epitopes on pathogens or diseased cells, leading to direct neutralization or the recruitment of immune effector mechanisms such as ADCC and CDC.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen and antigen targets recognized by IgG Fab.